Total Payments
$143,200
2024 Payments
$454.89
Companies
7
Transactions
125
Medicare Patients
1,014
Medicare Billing
$228,717
Payment Breakdown by Category
Consulting$113,537 (79.3%)
Other$13,560 (9.5%)
Travel$12,626 (8.8%)
Food & Beverage$3,305 (2.3%)
Education$172.07 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $113,537 | 33 | 79.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,560 | 2 | 9.5% |
| Travel and Lodging | $12,626 | 25 | 8.8% |
| Food and Beverage | $3,305 | 57 | 2.3% |
| Education | $172.07 | 8 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $128,728 | 95 | $0 (2024) |
| AstraZeneca UK Limited | $8,736 | 10 | $0 (2019) |
| Genentech USA, Inc. | $4,317 | 4 | $0 (2020) |
| Genentech, Inc. | $963.60 | 3 | $0 (2020) |
| Amgen Inc. | $317.10 | 5 | $0 (2017) |
| PFIZER INC. | $107.08 | 7 | $0 (2023) |
| F. Hoffmann-La Roche AG | $31.25 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $454.89 | 7 | AstraZeneca Pharmaceuticals LP ($454.89) |
| 2023 | $237.51 | 3 | AstraZeneca Pharmaceuticals LP ($219.74) |
| 2022 | $3,514 | 7 | AstraZeneca Pharmaceuticals LP ($3,425) |
| 2021 | $4,795 | 1 | AstraZeneca Pharmaceuticals LP ($4,795) |
| 2020 | $19,889 | 9 | AstraZeneca Pharmaceuticals LP ($18,860) |
| 2019 | $43,109 | 29 | AstraZeneca Pharmaceuticals LP ($37,233) |
| 2018 | $24,906 | 23 | AstraZeneca Pharmaceuticals LP ($22,765) |
| 2017 | $46,294 | 46 | AstraZeneca Pharmaceuticals LP ($40,976) |
All Payment Transactions
125 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $114.60 | General |
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $80.18 | General |
| Category: Oncology | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $52.39 | General |
| Category: Oncology | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $49.25 | General |
| Category: Oncology | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $45.26 | General |
| Category: Oncology | ||||||
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Oncology | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $91.04 | General |
| 06/03/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $104.36 | General |
| Category: Oncology | ||||||
| 02/24/2023 | AstraZeneca Pharmaceuticals LP | EVUSHELD (Drug) | Food and Beverage | In-kind items and services | $115.38 | General |
| Category: Vaccines & Immune Therapies | ||||||
| 01/24/2023 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $17.77 | General |
| Category: ONCOLOGY | ||||||
| 08/10/2022 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $12.00 | General |
| Category: ONCOLOGY | ||||||
| 07/20/2022 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $17.77 | General |
| Category: ONCOLOGY | ||||||
| 07/20/2022 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $12.00 | General |
| Category: ONCOLOGY | ||||||
| 03/22/2022 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $17.77 | General |
| Category: ONCOLOGY | ||||||
| 03/22/2022 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $12.00 | General |
| Category: ONCOLOGY | ||||||
| 02/17/2022 | PFIZER INC. | LORBRENA (Drug) | Education | In-kind items and services | $17.77 | General |
| Category: ONCOLOGY | ||||||
| 01/07/2022 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $3,425.00 | General |
| Category: Oncology | ||||||
| 05/11/2021 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $4,795.00 | General |
| Category: Oncology | ||||||
| 09/02/2020 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $4,450.00 | General |
| Category: Oncology | ||||||
| 09/02/2020 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $2,055.00 | General |
| Category: Oncology | ||||||
| 07/07/2020 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $3,425.00 | General |
| Category: Oncology | ||||||
| 06/16/2020 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $3,450.00 | General |
| Category: Oncology | ||||||
| 03/06/2020 | Genentech, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $243.36 | General |
| Category: None | ||||||
| 03/05/2020 | Genentech, Inc. | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $525.89 | General |
| Category: None | ||||||
| 03/05/2020 | Genentech, Inc. | Non-Covered Product (Drug) | Travel and Lodging | In-kind items and services | $194.35 | General |
| Category: None | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 214 | 491 | $197,784 | $47,785 |
| 2022 | 7 | 259 | 629 | $249,310 | $61,285 |
| 2021 | 6 | 270 | 667 | $245,004 | $67,605 |
| 2020 | 7 | 271 | 673 | $208,547 | $52,041 |
Total Patients
1,014
Total Services
2,460
Medicare Billing
$228,717
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 112 | 276 | $128,364 | $31,157 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 52 | 150 | $48,220 | $11,480 | 23.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 13 | 13 | $7,834 | $1,756 | 22.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 18 | 21 | $6,642 | $1,750 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 31 | $6,724 | $1,642 | 24.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 115 | 309 | $146,325 | $35,015 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 50 | 164 | $52,587 | $13,298 | 25.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 31 | 47 | $15,066 | $3,814 | 25.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 21 | 21 | $12,518 | $3,241 | 25.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 31 | $10,219 | $2,699 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 14 | 40 | $8,680 | $2,182 | 25.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 17 | $3,915 | $1,036 | 26.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 122 | 340 | $143,407 | $39,156 | 27.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 46 | 149 | $43,057 | $11,908 | 27.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 31 | 65 | $18,850 | $5,490 | 29.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 32 | 32 | $18,243 | $5,156 | 28.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 42 | $13,965 | $3,750 | 26.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 27 | 39 | $7,482 | $2,145 | 28.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 112 | 336 | $121,296 | $29,598 | 24.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 40 | 155 | $39,680 | $9,964 | 25.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 26 | 26 | $14,248 | $3,833 | 26.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 30 | 75 | $12,525 | $3,231 | 25.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 36 | 46 | $12,737 | $3,196 | 25.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 13 | 14 | $4,746 | $1,274 | 26.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 14 | 21 | $3,315 | $944.70 | 28.5% |
About Dr. Ronald Natale, M.D
Dr. Ronald Natale, M.D is a Specialist healthcare provider based in West Hollywood, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285734350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Natale, M.D has received a total of $143,200 in payments from pharmaceutical and medical device companies, with $454.89 received in 2024. These payments were reported across 125 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($113,537).
As a Medicare-enrolled provider, Natale has provided services to 1,014 Medicare beneficiaries, totaling 2,460 services with total Medicare billing of $228,717. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Medical Oncology
- Location West Hollywood, CA
- Active Since 09/25/2006
- Last Updated 03/07/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1285734350
Products in Payments
- TAGRISSO (Drug) $106,672
- IMFINZI (Drug) $23,952
- IMFINZI (Biological) $4,795
- Avastin (Biological) $4,150
- Non-Covered Product (Drug) $963.60
- TECENTRIQ (Biological) $198.16
- EVUSHELD (Drug) $115.38
- LORBRENA (Drug) $107.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in West Hollywood
Dr. James Berenson, M.d, M.D
Specialist — Payments: $2.1M
Specialist $2.1M
Ali Rezaie
Specialist — Payments: $756,521
Specialist $756,521
Jean Marie Lopategui, Md, MD
Specialist — Payments: $62,778
Specialist $62,778
Dr. Ajay Ananda, M.d, M.D
Specialist — Payments: $29,911
Specialist $29,911
Cynthia Nast, Md, MD
Specialist — Payments: $21,213
Specialist $21,213
Dr. Shahram Naiem, M.d, M.D
Specialist — Payments: $18,079
Specialist $18,079